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Figure 3. Spatial analysis of immunity distribution profiles was performed to 
account for spatial clustering of the different poultry production types (e.g. GP 
production is concentrated in 3 Governorates; 80% of the breeders are located in 6 
Governorates; 70% of the layers in 5 Governorates; 60% of the broilers and the 
total poultry population is concentrated in 4 Governorates). 
 
Table 2. Cost -Effectiveness Analysis 
ABSTRACT 
Vaccination against avian influenza (AI) is currently applied worldwide with inactivated vaccines. Since November 2012, a novel recombinant rHVT-AIH5 (Herpesvirus of turkeys as vector) vaccine has been 
commercialized and applied to day-old chicks (DOC) in some industrial hatcheries in Egypt (Kilany, 2014; Kilany, 2012). The objectives of this study were to assess the cost-effectiveness of AI DOC vaccination in 
hatcheries and the feasibility of implementing AI DOC vaccination in the different production sectors in Egypt.  
  
A model of the Egyptian poultry production network was combined with a model on flock immunity to simulate the distribution profile of AI immunity according to different vaccination scenarios (including DOC 
vaccination or not). The model estimated the levels of vaccine coverage for each node of the network and vaccination scenario and positive sero-conversion levels and the duration of sero-protection.   
   
The model predicted that targeting DOC AI vaccination in industrial and large size hatcheries would increase immunity levels in the overall poultry population in Egypt and especially in small commercial poultry 
farms (from <30% to >60%). This strategy was shown to be more efficient than the current strategy using inactivated vaccines. Improving HPAI control in the commercial poultry sector in Egypt would have a 
positive impact effect to improve disease control.  
  
This innovative way to analyze the outcome of AI immunity predictive model supports the design of a more efficient HPAI disease control plan in Egypt. This model may be replicated in other AIV endemic 
countries that wish to better manage infections or emerging disease threats. 
 
 
STUDY OBJECTIVES 
 
We combined network analysis of poultry production 
systems with an immunity model to study the distribution 
profile of avian influenza immunity in flocks through the 
commercial poultry production network in Egypt.  
 
The specific objectives were: 
1. To model the movement of DOC within the poultry value chain of 
Egypt  
2. To estimate vaccine coverage and sero-conversion levels 
according to different vaccination scenarios including DOC 
vaccination. 
 
CONCLUSIONS and PERSPECTIVES 
 
This study demonstrated the interest of combining network 
analysis and immunity modelling to assess the efficacy of AI 
vaccination scenarios in Egypt.  
 
The model predicted that targeting DOC AI vaccination in integrated 
and large hatcheries would increase immunity levels in the overall 
poultry population in Egypt, and especially in small commercial poultry 
farms, up to sufficient levels to improve HPAI disease control in Egypt.  
 
This strategy was shown to be more efficient than the current 
strategy using inactivated vaccines. This approach would have only 
marginal impact on immunity levels in Sector 4 household poultry. 
However, improving HPAI control in commercial poultry sector in Egypt 
could have positive spill over effect on the epidemiological situation of 
the disease in the household sector (Sector 4).  
 
Effectiveness assessment of this strategy and therefore field validation of 
the model outputs could be done by assessing the impact of DOC AI 
vaccination in pilot areas in Egypt, where it is already being implemented 
in Sector 1 and 2 hatcheries. Moreover, the impact of commercial DOC 
AI vaccination on the epidemiological situation of the disease in Sector 4 
could be assessed by increasing disease prevalence surveillance in 
LBMs in the areas where the AI vaccinated DOC would be applied. 
  
Bird Type Vaccine N° Doses Protection (%) 
Vaccination cost*  
(EPD**/100D) 
Breeders 
Inactivated 3-5 63-92% 84-140 
Vector+ Inactivated 1 92% 59.5 
Broilers 
Inactivated 1 10-33% 28 
Vector 1 50-80% 31.5 
Vector+ Inactivated 1 66% 59.5 
* Costs considered: vaccinator salary/ vaccinator supervision/ Vaccine cost/ DOC or bird 
losses/ Equipment/ Transportation 
**EPD = Egyptian Pounds 
The duration of sero-protection in long cycle birds (breeders and 
layers) could be significantly increased (up to 48%) with the prime boost 
vector/inactivated strategy (p<0.05). Implementing this prime boost 
strategy would also reduce the vaccination costs from 30 to 60% 
when compared to 3 or 5 doses inactivated vaccine protocols 
respectively. 
The results of the cost-benefit and break-even analysis highlighted the 
limitation of the current vaccination of broilers with inactivated vaccine 
which could never be efficient even if the risk of infection was 100%. 
The use of vector vaccines at day-old would be an efficient strategy to 
be used in the broiler production even at medium to low incidence levels 
(1% to 4% for prime-boost or single dose strategies respectively). 
 
Fig. 1: Network of the Egyptian poultry industry. A model network of the poultry 
industry was built up and analysed using Social Network Analysis method .  
 
Data were collected via literature review and cross sectional survey in a random 
selection of farms (n=140). Individual interviews with key stakeholders were performed to 
complete the data set.  
 
Analysis of network connectivity using the cut-point analysis was performed to assess 
the structure of the network and to identify nodes which have a key role in distribution of 
DOC through the network. Network connectivity and structural equivalence analysis were 
used to define the different DOC vaccination scenarios to be tested in the study. 
 
This network was used to model the distribution of the immunity profile within each 
node of the network based on different vaccination scenarios (Table 1). 
Immunity was assessed in terms of: 
- Vaccine coverage defined as the proportion of vaccinated birds from the total 
population considered.  
- Positive sero-conversion level was defined as the proportion of birds within the 
vaccinated population with haemagluttinin inhibition (HI) titers > 4Log2 (OIE, 2012). 
 
 
 
 
 
NETWORK MODELING 
 
RESULTS 
 
The model demonstrated a statistically significant increase of 
vaccination coverage (>80%; p<0.05) within the total population if 
hatchery vaccination was implemented in integrated and large 
farms (Sc. 4; Fig. 2(A)). By only vaccinating integrated DOC (Sc. 2), 
vaccine coverage in large and medium-sized farms would reach 80%. 
 
The model predicted that targeting DOC AI vaccination in 
industrial and large size hatcheries (Sc. 4) would increase 
immunity levels in the overall poultry population in Egypt and 
especially in small commercial poultry farms (from <30% to >60%) 
(Fig. 2(B)) (Bouma, 2009). 
 
Spatial analysis of AI immunity distribution demonstrated that 
under Sc.4 the immune level density  (both in terms of coverage 
and sero-protection) would increase above the threshold levels in 
the most at risk Governorates (Fig 3). 
 
DOC vaccination would be cost-effective either as prime-boost 
strategy with one boost of inactivated vaccine or as single dose 
vaccination both for long cycle and broiler birds whatever the 
current inactivated vaccination protocol in place (Table 2) .  
 
Figure 2(A). Evolution of the vaccine coverage rate per poultry 
production type, according to the different vaccination scenarios.  
Under baseline scenario (farm vaccination only), only the GP, breeders and 
integrated broilers have a sufficient level of coverage (>80%) 
Figure 2(B). Evolution of the positive sero-conversion rate per poultry 
production type, according to the different vaccination scenarios.  Under 
baseline scenario (farm vaccination only), only the GP, breeders have a 
sufficient level of sero-protection (>60%). 
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Table 1. VACCINATION SCENARIOS 
